GENEART AG is Awarded a European Patent for Successfully Tested HIV Vaccines
REGENSBURG, GERMANY--(Marketwire - April 09, 2008) -
- Complementary to the US American patent GENEART was awarded the European patent titled "Das Genom des HIV-1 Intersubtyps (C/B') und seine Anwendungen" ("The Genome of the HIV-1 Intersubtype (C/B') and Use Thereof")